To develop and optimize the world’s leading health and wellness ecosystem, complemented by cannabis derivatives.
MVMD is building a world-class health and wellness organization centred around cannabis derivatives and focused on the creation of industry leading products that are sought out globally.
Our proposition for delivering formulations that have rapid onset, with high bioavailability, with precision dosing technology, will be core to our success across key health and wellness categories, including pain management, weight loss, energy, focus, sleep, anxiety, libido and more. Core to our company’s science are our advanced desiccated liposome formulations and the related international patents for advanced compressible delivery formulations for transmucosal delivery.
MVMD believes its health and wellness success will be bolstered further through intelligent applications of cannabis-based cannabinoids across its transmucosal delivery product line and other health and wellness products. As such, MVMD also focuses on the areas of cultivation, research and development, and manufacturing through strategic acquisitions and partnerships, for the purposes of generating a market-leading portfolio of high quality, vertically-integrated, sustainable cannabis assets.
“The global cannabis industry is in the early innings of a major growth cycle and new markets are opening all over the globe.”
“As people incorporate more of the wellness values into their lifestyle, our interaction with the wellness economy is also becoming less episodic and more intentional, more integrative, and more holistic.”
“It is rare for new industries to emerge as rapidly as the cannabis sector has and even less common for Canadian enterprises to find themselves with a huge lead on foreign competition. International cannabis markets beckon Canadian LPs, who enjoy an abundance of capital and have the distinct advantage of operating in the world’s first fully legalized domestic marketplace.”
“Globally, it is estimated that about one in five, or about 1.5 billion people, suffer from chronic pain, with prevalence increasing with age.”
"Canada is poised to become the world leader in the growing cannabis industry. That potential I've never seen in my investment lifetime."
“In the face of longer lifespans, and rising chronic disease, stress and unhappiness, we only see growth for wellness ahead.”
MVMD is working on acquisitions and partnerships that will allow for the advancement in each the business plan pillars as outlined.
Unique Delivery Sciences.
An Unprecedented Opportunity.